Bio-Rad Laboratories, Inc. (BIO)
NYSE
Healthcare
Medical - Devices
$289.95
▲ +0.23%
Market Cap
$7.84B
Sector
Healthcare
Industry
Medical - Devices
Beta
1.08
52-Wk Range
227.53-343.12
CEO
Norman D. Schwartz
Country
US
Currency
USD
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical …
Open full interactive analysis & DCF →